IODINE-131 (Radiochemical)

Description

Overview:

Iodine-131 is a beta and gamma-emitting radioisotope essential in the diagnosis and treatment of thyroid disorders, including hyperthyroidism and thyroid cancer. Produced in nuclear reactors, I-131’s physical half-life of approximately 8 days makes it suitable for both therapeutic applications and imaging. SME Trading Corporation supplies certified Iodine-131 radiochemicals to hospitals, nuclear medicine centers, and research laboratories, ensuring compliance with strict safety, quality, and handling standards.

Key Features:

• High radiochemical purity and specific activity

• Supplied in forms compatible with diagnostic kits or therapeutic formulations

• Packaged with secure shielding and transport protocols

• Compliant with IAEA, WHO, and national regulatory guidelines

• Available in multiple activity levels tailored to clinical needs

Applications:

• Therapeutic treatment of thyroid cancer and hyperthyroidism

• Diagnostic imaging for thyroid function assessment

• Radiopharmaceutical preparation for patient-specific doses

• Research in nuclear medicine and radiobiology

Handling & Safety:

• Requires licensed facilities with radiation safety protocols

• Proper shielding and contamination prevention essential

• Strict adherence to disposal and decay management regulations